Oregon Therapeutics

Oregon Therapeutics

France - Paris
Biotechnology10 H-1B visas (FY2023)

Focus: Inhibition of protein disulfide isomerase

Oregon Therapeutics is a life sciences company focused on Inhibition of protein disulfide isomerase.

Open Jobs
0

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2021
Portfolio: 8 clinical trials
Top TAs: Gastroenterology, Hematology
H-1B (2023): 10 approvals
Therapeutic Area Focus
Hematology
1 pipeline
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
10
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub